4:12am PDT - October 13th, 2021
RT @LogycThaLion: $JNJ Johnson & Johnson's Janssen reports new subgroup analysis of the Phase 3 OPTIMUM study demonstrates the benefits of…
0 retweets 1 likes - Joe Gambiste (@Gambiste1)RT @LogycThaLion: $JNJ Johnson & Johnson's Janssen reports new subgroup analysis of the Phase 3 OPTIMUM study demonstrates the benefits of…
0 retweets 1 likes - Joe Gambiste (@Gambiste1)